The second part of the Teledyne Hanson’s Advances in In Vitro Bioequivalence Assessment for Topical Products – IVPT Focus webinar is going to be held on November 13, 2024. The attendance at the approx 45 minutes long presentation and the Q&A session is free but registration is needed:
| R E G I S T E R |
- The main objectives, principles and methodologies of an IVPT study
- The role of IVPT method as a surrogate alternative
- Membrane, media and permeation enhancers for IVPT
- Current challenges and future perspectives topical product bioequivalence
- Case studies providing practical, real-world examples of IVPT
Your expert presenter will be Dr. Theo Kapanadze, co-founder and chief scientific officer of Diteba Inc., a leader in dermal and transdermal research services. Diteba has been pivotal in advancing drug development and securing numerous innovator and generic drug approvals. Dr. Kapanadze has 20-plus years of research experience in analytical R&D chemistry and the pharmaceutical, biopharmaceutical, and nutraceutical industries. He earned his Ph.D. and D.Sc. in the chemistry of biological active compounds.
